155 related articles for article (PubMed ID: 6830832)
1. The thromboxane antagonist, 13-azaprostanoic acid, inhibits arachidonic acid-induced Ca2+ release from isolated platelet membrane vesicles.
Rybicki JP; Venton DL; Le Breton GC
Biochim Biophys Acta; 1983 Mar; 751(1):66-73. PubMed ID: 6830832
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo.
Le Breton GC; Lipowski JP; Feinberg H; Venton DL; Ho T; Wu KK
J Pharmacol Exp Ther; 1984 Apr; 229(1):80-4. PubMed ID: 6423815
[TBL] [Abstract][Full Text] [Related]
3. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.
Le Breton GC; Venton DL; Enke SE; Halushka PV
Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4097-101. PubMed ID: 291066
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
[TBL] [Abstract][Full Text] [Related]
5. Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes.
Hung SC; Ghali NI; Venton DL; Le Breton GC
Biochim Biophys Acta; 1983 Feb; 728(2):171-8. PubMed ID: 6219702
[TBL] [Abstract][Full Text] [Related]
6. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses.
Huzoor-Akbar ; Mukhopadhyay A; Anderson KS; Navran SS; Romstedt K; Miller DD; Feller DR
Biochem Pharmacol; 1985 Mar; 34(5):641-7. PubMed ID: 3156599
[TBL] [Abstract][Full Text] [Related]
8. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Patscheke H; Stegmeier K
Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
[TBL] [Abstract][Full Text] [Related]
9. 2-(6-carboxyhexyl)cyclopentanone hexylhydrazone: a potent inhibitor of the blood platelet cyclo-oxygenase.
Le Breton GC; Hung SC; Ghali NI; Venton DL
Prostaglandins; 1984 Apr; 27(4):543-51. PubMed ID: 6427851
[TBL] [Abstract][Full Text] [Related]
10. 9,11-epoxyiminoprosta-5,13-dienoic acid is a thromboxane A2 antagonist in human platelets.
Fitzpatrick FA; Bundy GL; Gorman RR; Honohan T
Nature; 1978 Oct; 275(5682):764-6. PubMed ID: 703845
[No Abstract] [Full Text] [Related]
11. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
[TBL] [Abstract][Full Text] [Related]
12. Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
Patscheke H; Stegmeier K
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():371-3. PubMed ID: 3159225
[No Abstract] [Full Text] [Related]
13. Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.
Pollock WK; Armstrong RA; Brydon LJ; Jones RL; MacIntyre DE
Biochem J; 1984 May; 219(3):833-42. PubMed ID: 6234886
[TBL] [Abstract][Full Text] [Related]
14. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
[TBL] [Abstract][Full Text] [Related]
15. Prostacyclin potentiates 13-azaprostanoic acid-induced platelet deaggregation.
Parise LV; Venton DL; Le Breton GC
Thromb Res; 1982 Dec; 28(6):721-30. PubMed ID: 6301090
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1982 Jul; 222(1):276-81. PubMed ID: 7086705
[TBL] [Abstract][Full Text] [Related]
17. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
18. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
Kowalska MA; Rao AK; Disa J
Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
[TBL] [Abstract][Full Text] [Related]
19. Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2.
Fitzpatrick FA; Gorman RR
Prostaglandins; 1977 Nov; 14(5):881-9. PubMed ID: 594390
[TBL] [Abstract][Full Text] [Related]
20. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
Quilley J; McGiff JC; Nasjletti A
Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]